Northern Trust’s Allena Pharmaceuticals ALNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-89,363
| Closed | -$17K | – | 4791 |
|
|
2022
Q2 | $17K | Hold |
89,363
| – | – | ﹤0.01% | 4647 |
|
|
2022
Q1 | $21K | Hold |
89,363
| – | – | ﹤0.01% | 4667 |
|
|
2021
Q4 | $53K | Hold |
89,363
| – | – | ﹤0.01% | 4585 |
|
|
2021
Q3 | $81K | Buy |
89,363
+24,064
| +37% | +$23.6K | ﹤0.01% | 4455 |
|
|
2021
Q2 | $85K | Hold |
65,299
| – | – | ﹤0.01% | 4403 |
|
|
2021
Q1 | $91K | Buy |
65,299
+870
| +1% | +$1.45K | ﹤0.01% | 4299 |
|
|
2020
Q4 | $82K | Buy |
64,429
+35,626
| +124% | +$49.7K | ﹤0.01% | 4154 |
|
|
2020
Q3 | $43K | Buy |
28,803
+9,258
| +47% | +$13K | ﹤0.01% | 4124 |
|
|
2020
Q2 | $31K | Sell |
19,545
-1,064
| -5% | -$1.79K | ﹤0.01% | 4115 |
|
|
2020
Q1 | $20K | Hold |
20,609
| – | – | ﹤0.01% | 4093 |
|
|
2019
Q4 | $56K | Hold |
20,609
| – | – | ﹤0.01% | 4039 |
|
|
2019
Q3 | $81K | Sell |
20,609
-92,336
| -82% | -$396K | ﹤0.01% | 3961 |
|
|
2019
Q2 | $460K | Sell |
112,945
-7,809
| -6% | -$42.7K | ﹤0.01% | 3577 |
|
|
2019
Q1 | $848K | Sell |
120,754
-342
| -0.3% | -$2.48K | ﹤0.01% | 3413 |
|
|
2018
Q4 | $660K | Sell |
121,096
-196
| -0.2% | -$1.69K | ﹤0.01% | 3487 |
|
|
2018
Q3 | $1.3M | Buy |
121,292
+7,311
| +6% | +$80.4K | ﹤0.01% | 3391 |
|
|
2018
Q2 | $1.49M | Buy |
113,981
+55,238
| +94% | +$797K | ﹤0.01% | 3349 |
|
|
2018
Q1 | $648K | Hold |
58,743
| – | – | ﹤0.01% | 3502 |
|
|
2017
Q4 | $591K | Buy |
+58,743
| New | +$724K | ﹤0.01% | 3525 |
|
Other funds holding ALNA
Northern Trust's ALNA Position: Q3 2022 in Review
Northern Trust sold out of Allena Pharmaceuticals (ALNA) in Q3 2022, closing a stake of 89,363 shares — an estimated $17K sold.
Northern Trust first reported a position in ALNA in Q4 2017 and held it in 19 quarters. The position peaked at $1.49M in Q2 2018. 2 funds tracked by Wall St. Rank hold ALNA as of Q3 2022.
- Northern Trust reported no remaining Allena Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
- Northern Trust sold 89,363 Allena Pharmaceuticals shares in Q3 2022, an estimated $17K.
- Northern Trust first reported a position in Allena Pharmaceuticals in Q4 2017 and held it in 19 quarters.
- Northern Trust's Allena Pharmaceuticals position peaked at $1.49M in Q2 2018.
- 2 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q3 2022.
Based on Northern Trust's 13F filing for Q3 2022, filed 14 Nov 2022.